Rapid molecular point of care testing
Active Blanket Purchase Agreement Awarded Last action
- Contract number
- 36C25924A0042
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 3 $654,346 obligated
Award facts
- Opportunity
-
- 6550--Rapid Molecular Point of Care COVID-FLU-STREP Testing for Oklahoma City VA Healthcare System Pre-Solicitation · 36C25924Q0385 · Posted Jun 17, 2024
- Combined order value
- $654,346 Current and potential, with all options
- Last date to order 44% complete
- IDV ceiling 30% used
- $2,209,150.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 19 (VISN 19), a civilian component of the Department of Veterans Affairs, established a Blanket Purchase Agreement with Roche Diagnostics Corporation on August 1, 2024, for rapid molecular point-of-care testing, with a ceiling of $2,209,150 and an ultimate completion date of July 31, 2029.
The BPA was established to supply waived rapid molecular point-of-care testing capable of simultaneously detecting SARS-CoV-2, influenza A, influenza B, and streptococcus A from nasal, nasopharyngeal, or throat swab specimens at the Oklahoma City VA Healthcare System. Place of performance is Oklahoma City, Oklahoma. The NAICS code is 334516 and the Product Service Code is 6550.
Recent BPA calls under this vehicle include a $69,454.80 firm fixed-price call awarded August 1, 2024, for molecular point-of-care reagent rental services with performance through January 31, 2025; a $143,061.20 firm fixed-price call awarded February 24, 2025, for rapid molecular point-of-care testing services with performance through January 31, 2026; and a $441,830 firm fixed-price call awarded February 1, 2026, for rapid molecular point-of-care testing services with performance through January 31, 2027. All calls were performed in Oklahoma City, Oklahoma, and carried no set-aside designation.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Rapid molecular point of care testing | Veterans Integrated Service Network 19 (VHA) | $441,830 | |
| Rapid molecular point of care testing | Veterans Integrated Service Network 19 (VHA) | $143,061 | |
| Oklahoma city VA molecular point of care reagent rental agreement ordering period 1 funding | Veterans Integrated Service Network 19 (VHA) | $69,455 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25924A0042?
36C25924A0042 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on August 1, 2024.
How much is contract 36C25924A0042 worth?
Orders under 36C25924A0042 have obligated $654,346. 36C25924A0042's own ceiling is $2,209,150.
How many orders have been placed under contract 36C25924A0042?
3 orders have been placed under 36C25924A0042, the latest on February 1, 2026.
Who can order from contract 36C25924A0042?
36C25924A0042 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV